Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 3 of 3 items for :

  • "salvage treatment" x
Clear All
Xian Qiu Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Search for other papers by Xian Qiu in
Google Scholar
PubMed Close
,
Lin Cheng Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Search for other papers by Lin Cheng in
Google Scholar
PubMed Close
,
Ri Sa Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China

Search for other papers by Ri Sa in
Google Scholar
PubMed Close
,
Hao Fu Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China

Search for other papers by Hao Fu in
Google Scholar
PubMed Close
,
Yuchen Jin Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Search for other papers by Yuchen Jin in
Google Scholar
PubMed Close
, and
Libo Chen Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Search for other papers by Libo Chen in
Google Scholar
PubMed Close

into two clinical situations: TKI-naive patients with RR-DTC diagnosed after 131 I therapy (initial treatment group) and patients with RR-DTC who had failed to first-line sorafenib treatment (salvage treatment group). Patients with concurrent cancers

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-21-0065
Volume/Issue:
Volume 11: Issue 2
Open access
Zhen Gao The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Zhen Gao in
Google Scholar
PubMed Close
,
Hongtao Zhang The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Hongtao Zhang in
Google Scholar
PubMed Close
,
Lijuan Zhang The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Lijuan Zhang in
Google Scholar
PubMed Close
,
Huimin Yu The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Huimin Yu in
Google Scholar
PubMed Close
,
Xuemin Di The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Xuemin Di in
Google Scholar
PubMed Close
,
Zeyang Wang The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Zeyang Wang in
Google Scholar
PubMed Close
,
Zezhou Liu The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Zezhou Liu in
Google Scholar
PubMed Close
,
Aixia Sui The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Aixia Sui in
Google Scholar
PubMed Close
,
Juan Wang The First Department of Oncology, Hebei General Hospital, Shijiazhuang, China

Search for other papers by Juan Wang in
Google Scholar
PubMed Close
, and
Gaofeng Shi Department of Radiology, The 4th Affiliated Hospital of Hebei Medical University, Shijiazhuang, China

Search for other papers by Gaofeng Shi in
Google Scholar
PubMed Close

-guided 125 I seed brachytherapy as salvage treatment. A literature search of PubMed shows that there is only one other study on the use of 125 I seed implantation for the treatment of recurrent PTC. In this previous study by Parker et al. [ 13 ], a patient

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000519572
Volume/Issue:
Volume 10: Issue 6
Open access
Samuel Chan Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Samuel Chan in
Google Scholar
PubMed Close
,
Katarina Karamali Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Katarina Karamali in
Google Scholar
PubMed Close
,
Anna Kolodziejczyk Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Anna Kolodziejczyk in
Google Scholar
PubMed Close
,
Georgios Oikonomou Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Georgios Oikonomou in
Google Scholar
PubMed Close
,
John Watkinson Department of Ear, Nose, and Throat Surgery, GOSH, London, United Kingdom

Search for other papers by John Watkinson in
Google Scholar
PubMed Close
,
Vinidh Paleri The Royal Marsden Hospital, London, United Kingdom

Search for other papers by Vinidh Paleri in
Google Scholar
PubMed Close
,
Iain Nixon Department of Ear, Nose, and Throat Surgery, NHS Lothian, University of Edinburgh, Edinburgh, United Kingdom

Search for other papers by Iain Nixon in
Google Scholar
PubMed Close
, and
Dae Kim Department of Ear, Nose, and Throat Surgery, St George’s Hospital, London, United Kingdom

Search for other papers by Dae Kim in
Google Scholar
PubMed Close

WDTC.” Ease of salvage treatment is dependent on the site of recurrence, with patients presenting with multiple surgeries or distant metastases demonstrating significantly worse overall or disease-specific survival, or disease control [ 29 - 32 ]. In

Article Type:
Systematic Review
DOI:
https://doi.org/10.1159/000504961
Volume/Issue:
Volume 9: Issue 2
Free access